Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by KAPLAN, H. S.
Right arrow Articles by NAGAREDA, C. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by KAPLAN, H. S.
Right arrow Articles by NAGAREDA, C. S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, 1961, Vol. 18, No. 2, pp. 166-175.
© 1961 American Society of Hematology, Inc.


On the Possibility of Cure of Malignant Lymphoid Tumors. I. Treatment of Autochthonous Lymphoid Tumors in C57BL Mice with Massive Doses of Lymphocytolytic Agents

HENRY S. KAPLAN 1 and C. SUSAN NAGAREDA 1

1 Department of Radiology, Stanford University School of Medicine, Stanford, Calif.

Strain C57B1 mice in which thymic lymphosarcomas had been induced with total-body X-radiation were treated, at various times in the course of tumor development, with either hydrocortisone or local X-irradiation. Their survival was compared with that of placebo-treated controls. In other sacrificed control groups, the incidence and extent of lymphoma development at the time of treatment was established by microscopic examination.

Treatment with single massive doses of hydrocortisone or local thymic X-irradiation at 50 or 100 days after lymphoma induction resulted in permanent cure of half or more of the animals. For a given dose, hydrocortisone was equally effective when given at any time interval up to 100 days after the start of lymphoma induction. However, the therapeutic efficacy of hydrocortisone was a significant function of hormone dose, over the range 0.3 to 3.0 mg. In addition to the cure of many animals, significant prolongation of life was noted in animals dying of lymphomas in all of the treated groups.

Submitted on January 3, 1961
Accepted on March 17, 1961


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
ANN INTERN MEDHome page
R. A. KYLE, C. E. MCPARLAND, and W. DAMESHEK
Large Doses of Prednisone and Prednisolone in the Treatment of Malignant Lymphoproliferative Disorders
Ann Intern Med, November 1, 1962; 57(5): 717 - 731.
[Abstract] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1961 by American Society of Hematology         Online ISSN: 1528-0020